6
/ Wednesday, January 22, 2020
Leaders in the pharmaceutical and biotechnology industries to headline event detailing how these businesses have thrived locally despite an array of challenges. >Archive
Corporate Compliance Seminar Seeks to Expand Business Growth
The event will feature discussions on local and international ethical and legal affairs to foster exportation
A Giovanna Garofalo
ggarofalo@wjournalpr.com
@giopgarofalo
n upcoming seminar aims to modernize the corporate culture in Puerto Rico’s private sector in light of growing exportation opportunities by providing the tools on how to expand businesses while
upholding accessibility ethically. The ‘Corporate Compliance and Ethics Infractions Seminar’—organized by business law firm Zeichner Ellman and Krause (ZEK)—will explore the characteristics of a robust corporate compliance program equipped to detect corrupt solicitation, receive and address whistleblower complaints, and tackle global and internal investigations. ZEK Partner Aixa Maldonado explained that the seminar is focused on encouraging corporations to “take production risks” and thrive in a global economy. “We have scheduled this seminar and have invited the companies that do business on the island; it is designed for the sales and contracting departments, legal offices and the management of these corporations because what we want to
do is try to educate and equip these corporations to expand or think of expanding in terms of doing business outside the island while also offering other products,” Maldonado told THE WEEKLY JOURNAL. According to Maldonado, the seminar will feature several panels hosted by experts in various fields to discuss the policies that a company should adopt to stay in line with legal requirements and regulations from their respective industries, how different businesses have modified their management to increase their accessibility and how to identify the right distributor for one’s business, among others. The first panel will feature Wendy Perry, president of the Puerto Rico Pharmaceutical Association (PIA), and Sol Rosado, president of the Puerto Rico Agricultural Biotechnology